New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 14, 2014
10:25 EDTEWEdwards Lifesciences rises sharply following court action, upgrades
The stock is up 13.6% to $82.97 following a U.S. District Court preliminary injunction that limits sales of Medtronic's (MDT) CoreValve system in the United States. JPMorgan and CRT Capital upgraded the name to Neutral and Buy, respectively. Wells Fargo upped its price target to $90 to $91. At current price the next major resistance level is at $86.11, the 52-week high. Support is at $81.93, the opening price of the day.
News For EW From The Last 14 Days
Check below for free stories on EW the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 25, 2014
10:13 EDTEWHigh option volume stocks
Subscribe for More Information
06:34 EDTEWEdwards Lifesciences price target raised to $120 from $95 at Piper Jaffray
Piper Jaffray raised its price target for Edwards Lifesciences shares to $120 saying recent Transcatheter Aortic Valve Replacement market momentum is likely to continue. The firm keeps an Overweight rating on the stock.
September 18, 2014
09:19 EDTEWGeneration Investment reports 5.2% passive stake in Edwards Lifesciences
September 16, 2014
07:27 EDTEWEdwards Lifesciences price target raised to $114 from $103 at Canaccord
Canaccord raised its price target on Edwards Lifesciences to $114 from $103 following positive updates on the SAPIEM franchise and on the heels of several positive trends and upside surprises across the businesses during the quarter. Canaccord maintains its Buy rating on the stock.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use